Citations as recorded by:

1. MicroRNAs in the prognosis of triple-negative breast cancer

Medicine, 2017, 96(22) p. e7085

DOI: 10.1097/MD.0000000000007085

Citations as recorded by: Cross Ref PMC

2. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival

The Breast, 2017, 32 p. 18

DOI: 10.1016/j.breast.2016.12.007

Citations as recorded by: Cross Ref Google

3. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics

Med Sci Monit, 2017, 23 p. 1857

DOI: 10.12659/MSM.900030

Citations as recorded by: Cross Ref PMC

4. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction

Pharmacology & Therapeutics, 2017, 172 p. 34

DOI: 10.1016/j.pharmthera.2016.11.012

Citations as recorded by: Cross Ref Google

5. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer

Year: 2017

Citations as recorded by: Google

6. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and …

Year: 2017

Citations as recorded by: Google

7. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach

Year: 2017

Citations as recorded by: Google

8. MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis

Year: 2017

Citations as recorded by: Google

9. mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27

Oncotarget, 2016, 8 p. 6304

DOI: 10.18632/oncotarget.13850

Citations as recorded by: PMC Google

10. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.

Biochem. Biophys. Res. Commun., 2016, 469 p. 5

DOI: S0006-291X(15)30940-2

Citations as recorded by: Google

11. Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer

35(2) p. 1135

DOI: 10.3892/or.2015.4451

Citations as recorded by: Cross Ref Google

12. Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics

The Breast, 2016, 28 p. 148

DOI: 10.1016/j.breast.2016.05.014

Citations as recorded by: Cross Ref Google

13. Methylation Status of SP1 Sites within miR-23a-27a-24-2 Promoter Region Influences Laryngeal Cancer Cell Proliferation and Apoptosis

BioMed Research International, 2016, 2016 p. 1

DOI: 10.1155/2016/2061248

Citations as recorded by: Cross Ref PMC Google

14. MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR signaling pathway.

Eur Rev Med Pharmacol Sci, 2016, 20 p. 2

DOI: 1

Citations as recorded by: Google

15. RGD-conjugated mesoporous silica-encapsulated gold nanorods enhance the sensitization of triple-negative breast cancer to megavoltage radiation therapy

Int J Nanomedicine, 2016, 11 p. 5595

DOI: 10.2147/IJN.S104034

Citations as recorded by: PMC Google

16. MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7

Med Sci Monit, 2015, 21 p. 2828

DOI: 10.12659/MSM.895660

Citations as recorded by: Cross Ref PMC Google

17. Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?

Front. Med., 2015, 2

DOI: 10.3389/fmed.2015.00085

Citations as recorded by: Cross Ref PMC Google